中文名 | Etalocib |
英文名 | Etalocib |
别名 | 化合物ETALOCIB 2-(3-(3-((5-乙基-4'-氟-2-羟基-[1,1'-联苯]-4-基)氧基)丙氧基)-2-丙基苯氧基)苯甲酸 |
英文别名 | VML 295 Etalocib LY293111 LY293111 Exclusive YFIZRWPXUYFCSN-UHFFFAOYSA-N 2-(3-(3-((5-Ethyl-4'-fluoro-2-hydroxy-[1,1'-biphenyl]-4-yl)oxy)propoxy)-2-propylphenoxy)benzoic acid Benzoic acid, 2-[3-[3-[(5-ethyl-4'-fluoro-2-hydroxy[1,1'-biphenyl]-4-yl)oxy]propoxy]-2-propylphenoxy]- |
CAS | 161172-51-6 |
化学式 | C33H33FO6 |
分子量 | 544.61 |
密度 | 1?+-.0.06 g/cm3(Predicted) |
熔点 | 68-70 °C(Solv: acetonitrile (75-05-8)) |
沸点 | 656.8±55.0 °C(Predicted) |
溶解度 | 溶于DMSO |
酸度系数 | 3.32±0.36(Predicted) |
存储条件 | -20℃ |
参考资料 展开查看 | 1: Saif MW, Oettle H, Vervenne WL, Thomas JP, Spitzer G, Visseren-Grul C, Enas N, Richards DA. Randomized double-blind phase II trial comparing gemcitabine plus LY293111 versus gemcitabine plus placebo in advanced adenocarcinoma of the pancreas. Cancer J. 2009 Jul-Aug;15(4):339-43. PubMed PMID: 19672152. 2: Adrian TE, Hennig R, Friess H, Ding X. The Role of PPARgamma Receptors and Leukotriene B(4) Receptors in Mediating the Effects of LY293111 in Pancreatic Cancer. PPAR Res. 2008;2008:827096. Epub 2009 Jan 27. PubMed PMID: 19190780; PubMed Central PMCID: PMC2631651. 3: Tong WG, Ding XZ, Talamonti MS, Bell RH, Adrian TE. Leukotriene B4 receptor antagonist LY293111 induces S-phase cell cycle arrest and apoptosis in human pancreatic cancer cells. Anticancer Drugs. 2007 Jun;18(5):535-41. PubMed PMID: 17414622. 4: Baetz T, Eisenhauer E, Siu L, MacLean M, Doppler K, Walsh W, Fisher B, Khan AZ, de Alwis DP, Weitzman A, Brail LH, Moore M. A phase I study of oral LY293111 given daily in combination with irinotecan in patients with solid tumours. Invest New Drugs. 2007 Jun;25(3):217-25. Epub 2006 Dec 5. PubMed PMID: 17146732. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 1.836 ml | 9.181 ml | 18.362 ml |
5 mM | 0.367 ml | 1.836 ml | 3.672 ml |
10 mM | 0.184 ml | 0.918 ml | 1.836 ml |
5 mM | 0.037 ml | 0.184 ml | 0.367 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!